VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹315 Cr | ₹280 Cr | ₹240 Cr | ₹185 Cr | ₹137 Cr |
What is the latest Net Current Assets ratio of VENUS REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹315 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹185 Cr |
| Mar2021 | ₹137 Cr |
How is Net Current Assets of VENUS REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹315 Cr | 12.61 | |
| Mar2024 | ₹280 Cr | 16.58 | |
| Mar2023 | ₹240 Cr | 29.66 | |
| Mar2022 | ₹185 Cr | 35.66 | |
| Mar2021 | ₹137 Cr | - | |
Compare Net Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,114.1 Cr | 12.6% | 10.5% | 168.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 12.6% |
10.5% |
168.2% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses